14930146 · Active · incorporated 3 years, 4 months ago · London
Biotech AI Biotech & Life Sciences Drug Discovery Series B+
Trogenix is a biotechnology company developing AAV gene therapies and Synthetic Super Enhancers for cancer treatment.
Trogenix Ltd is a private limited company registered at Companies House under number 14930146, incorporated on 12 June 2023, with a registered office in London. Its current status on the register is active. Its filed nature of business is research and experimental development on biotechnology (SIC 72110). Sonde has indexed 48 filings for this company, including 4 funding rounds. Its most recent round closed in October 2026, raising £17.1m.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 4 | Oct 2026 | £17.1m | £170.00 |
| Round 3 | Oct 2025 | £18.2m | £170.00 |
| Round 2 | Dec 2024 | £9m | £100.00 |
| Round 1 | Feb 2024 | £3.5m | £100.00 |
Showing the 10 most recent of 48 filings.
See the complete cap table with every shareholder, founder tags, dilution across 13 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.